|
Independent validation of paige prostate: Assessing clinical benefit of an artificial intelligence tool within a digital diagnostic pathology laboratory workflow. |
|
|
|
Stock and Other Ownership Interests - PAIGE.AI |
Patents, Royalties, Other Intellectual Property - PAIGE.AI |
|
|
|
Stock and Other Ownership Interests - PAIGE.AI |
Patents, Royalties, Other Intellectual Property - PAIGE.AI |
|
|
Employment - HeartFlow; PAIGE.AI |
Leadership - HeartFlow; PAIGE.AI |
Stock and Other Ownership Interests - HeartFlow; PAIGE.AI |
Consulting or Advisory Role - Inheart |
Patents, Royalties, Other Intellectual Property - HeartFlow; PAIGE.AI |
|
|
|
|
Stock and Other Ownership Interests - PAIGE.AI |
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center; PAIGE.AI |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Context Therapeutics; Lilly; Novartis; Paige.ai; Revolution Medicines; Sermonix Pharmaceuticals |
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Sun Pharma |
|
|
Consulting or Advisory Role - Genentech/Roche; Goldman Sachs; Invicro; Novartis; Paige.AI; Repare Therapeutics; Ventana Medical Systems; Volition RX |
|
|
No Relationships to Disclose |
|
Leonard Medeiros da Silva |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Grupo Oncoclinicas |